Trackflex

Trackflex Sirolimus Eluting Stent

AI-designed ultra-thin stent with superior flexibility, strength, and deliverability

Advanced Design & Drug Delivery Technology

Semi-Compliant PTCA Balloon Catheter Designed Specifically for Pre-dilation and Drug/Stent Delivery

Maximum Pushbility -TranSmoothTM Technology Enhanced Deliverability

Deep Embedding – Optimized strut architecture ensures deep vessel wall embedding, enhancing crossability and improving stent stability.

Coating Integrity – Homogeneous drug coating encapsulated within a biodegradable polymer matrix ensures uniform drug distribution at the treated lesion and maintains coating integrity during delivery.

Drug Release Profile

Trackflex has proven drug release kinetics. Initial burst of Trackflex followed by sustained release up to 50 Days. Biodegradable polymers completely degrade by hydrolysis & enzymatilc degradation which is eventually exreted from body in from of Co and H2O.

A very fine drug-polymer thickness of 3-5µm reduces tissue polymer contact which eventually resulted into fast remodelling of artery.

Proprietary blend of Sirolisum drug & Biodegradable polymers provides the initial burst release, following to 80% within 30 days and remaining 20% programmed to get released for 60 days. Release kinetics was designed to enhance the arterial healing process.

Key features and benefits

Ultra thin struts 65 µ

Lower inflammation, faster endothelisation and reduces the risk of stent thrombosis

Biodegradable Polymer

Offers improved vessel healing, long term safety in terms of death, stent thrombosis and myocardial infarction.

Everolimus drug

Time tested and proven drug

Negligible foreshortening

Ideal for ostial and bifurcation lesions

AI derived stent design

Designed to improve trackability and flexibility of the stent leading to first choice of stent in CHIP cases.

Higher tensile strength

Attributes to kink resistance and flexible performance of SDS

Uniform stent design

Leads to unidirectional stent expansion reducing chances of vessel injury

Wavy strut pattern

Contributes to larger angle during expansion eventually leading to better stent flexibility

Ideal overexpansion limits

Leads to treat complex cases with anatomical anomanlies

Ultr low tip profile

Gives resistance free trackability and crossability

Platinum iridium markers

Precisely placed within balloon cones for accurate stent positioning & placement

Low recoil

Avoids the risk of malposition and restenosis

Ordering Information

Stent Diameter (mm)	8 mm	13 mm	16 mm	20 mm	24 mm	28 mm	32 mm	36 mm	40 mm	43 mm	47 mm	Over Expansion (mm)
2	TF20008	TF20013	TF20016	TF20020	TF20024	TF20028	TF20032	TF20036	TF20040	TF20043	TF20047	3.5
2.25	TF22508	TF22513	TF22516	TF22520	TF22524	TF22528	TF22532	TF22536	TF22540	TF22543	TF22547	3.5
2.5	TF25008	TF25013	TF25016	TF25020	TF25024	TF25028	TF25032	TF25036	TF25040	TF25043	TF25047	3.5
2.75	TF27508	TF27513	TF27516	TF27520	TF27524	TF27528	TF27532	TF27536	TF27540	TF27543	TF27547	4.5
3	TF30008	TF30013	TF30016	TF30020	TF30024	TF30028	TF30032	TF30036	TF30040	TF30043	TF30047	4.5
3.5	TF35008	TF35013	TF35016	TF35020	TF35024	TF35028	TF35032	TF35036	TF35040	TF35043	TF35047	4.5
4	TF40008	TF40013	TF40016	TF40020	TF40024	TF40028	TF40032	TF40036	TF40040	TF40043	TF40047	5.5
4.5	TF45008	TF45013	TF45016	TF45020	TF45024	TF45028	TF45032	TF45036	TF45040	TF45043	TF45047	5.5

Stent Specification

Design	Open cell with unique alternate LDS link
Material	L-605 Cobalt Chromium
Drug	Everolimus
Drug Dose	1.2 µm m²
Polymer	Biodegradable and Biocompatible
Strut Thickness	65 µ
Diameter (mm)	2, 2.25, 2.5, 2.75, 3, 3.5, 4 & 4.5
Length (mm)	8, 13, 16, 20, 24, 28, 32, 36, 40, 43 & 47
Recoil	≤ 5%
Delivery System	Rapid Exchange
Tip Entry Profile (mm)	0.016”

Crossing Profile (mm)	0.038” (3x20mm)
Guide Catheter Compatibility	5 F
Guidewire Compatibility	0.014”
Nominal Pressure	9 atm
Rated Burst Pressure	16 atm
Shaft Length	145 cm
Balloon Overhang	≤ 0.5 mm
Proximal Shaft Diameter†	2.13 F
Distal Shaft Diameter†	2.7 F